Literature DB >> 6728037

Evidence against the adenosine-catecholamine antagonism under in vivo conditions.

R Seitelberger, W Schütz, O Schlappack, G Raberger.   

Abstract

Experiments were carried out in anaesthetized, thoracotomized dogs. The dose dependent positive inotropic and chronotropic effects of intracoronary (i.cor.) infusions or bolus injections of isoproterenol (ISO) were neither antagonized by adenosine (0.46, 1.0, and 2.91 x 10(-5) mol/l) nor by the adenosine analogue N6-phenylisopropyl-adenosine (PIA, 3.23 x 10(-7) mol/l). The results indicate, that adenosine and PIA do not have any antagonistic effects on isoproterenol induced positive inotropy and chronotropy in the intact dog heart. Consequently it can be assumed that an adenosine-catecholamine antagonism is of no physiological relevance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728037     DOI: 10.1007/BF00495949

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

Review 1.  THE NONVASCULAR METABOLIC MYOCARDIAL VULNERABILITY FACTOR IN "CORONARY HEART DISEASE". FUNDAMENTALS OF PATHOGENESIS, TREATMENT, AND PREVENTION.

Authors:  W RAAB
Journal:  Am Heart J       Date:  1963-11       Impact factor: 4.749

2.  Plasma catechol amine concentrations in myocardial infarction and angina pectoris.

Authors:  P C GAZES; J A RICHARDSON; E F WOODS
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

3.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

4.  Blood plasma catecholamines and their urinary excretion in patients with acute myocardial infarction.

Authors:  P E Lukomsky; R G Oganov
Journal:  Am Heart J       Date:  1972-02       Impact factor: 4.749

5.  Plasma-catecholamines after cardiac infarction.

Authors:  L McDonald; C Baker; C Bray; A McDonald; N Restieaux
Journal:  Lancet       Date:  1969-11-15       Impact factor: 79.321

6.  The reflex stimulation of catecholamine secretion during the acute stage of myocardial infarction in the dog.

Authors:  J Staszewska-Barczak
Journal:  Clin Sci       Date:  1971-11       Impact factor: 6.124

7.  Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance.

Authors:  R Rubio; R M Berne
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

8.  Effects of adenosine and ATP on AV conduction and on AV junctional rhythm.

Authors:  F Urthaler; T N James
Journal:  J Lab Clin Med       Date:  1972-01

9.  Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction.

Authors:  C Valori; M Thomas; J Shillingford
Journal:  Am J Cardiol       Date:  1967-11       Impact factor: 2.778

10.  Release of adenosine from human hearts during angina induced by rapid atrial pacing.

Authors:  A C Fox; G E Reed; E Glassman; A J Kaltman; B B Silk
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  4 in total

1.  Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium.

Authors:  M Ungerer; M Böhm; R H Schwinger; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

2.  Pharmacological characteristics of adenosine-induced inhibition of dog ventricular contractility: dependence on the pre-existing level of beta-adrenoceptor activation.

Authors:  M Endoh; H Kushida; I Norota; M Takanashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

3.  Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding.

Authors:  M J Lohse; D Ukena; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

4.  Interaction of amrinone with endogenous adenosine in guinea-pig atria.

Authors:  P Dorigo; I Maragno
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.